Neurotherapeutics
ISSN:1933-7213

Neurotherapeutics

NEUROTHERAPEUTICS
学科领域:医学
是否预警:不在预警名单内
是否OA:
录用周期:较慢,6-12周
新锐分区:医学1区
年发文量:142
影响因子:6.9
JCR分区:Q1

基本信息

神经治疗学®是美国实验神经治疗学会(ASENT)的期刊。每一期都对国际权威撰写的神经疾病治疗相关的重要主题进行评论。该杂志还发表转化神经科学的原创研究文章,包括对跨学科前沿疗法的描述,并代表了该领域医生和其他研究人员对神经治疗学的重要贡献。Neurotherapeutics ®提供了转化神经科学前沿的多学科视角,提供了当前研究和实践的视角,涵盖了社会和伦理以及科学问题。
1933-7213SCIE/Scopus收录/DOAJ开放期刊
6.9
7
2026年3月发布
点击查看历史分区趋势    >
大类学科小类学科Top期刊综述期刊
医学1区
CLINICAL NEUROLOGY 临床神经病学
2区
NEUROSCIENCES 神经科学
2区
PHARMACOLOGY & PHARMACY 药学
1区
N/A
WOS期刊SCI分区  2024-2025最新升级版
按JIF指标学科分区收集子录JIF分区JIF排名百分位
学科:CLINICAL NEUROLOGY
SCIE
Q1
22/286
学科:NEUROSCIENCES
SCIE
Q1
28/314
学科:PHARMACOLOGY & PHARMACY
SCIE
Q1
24/352
按JCR指标学科分区收集子录JCR分区JCR排名百分位
学科:CLINICAL NEUROLOGY
SCIE
Q1
31/286
学科:NEUROSCIENCES
SCIE
Q1
38/314
学科:PHARMACOLOGY & PHARMACY
SCIE
Q1
27/353
100
142
5%-较慢,6-12周-医学-神经科学
1.4%
时间预警情况
2026年03月发布的新锐学术版不在预警名单中
2025年03月发布的2025版不在预警名单中
2024年02月发布的2024版不在预警名单中
2023年01月发布的2023版不在预警名单中
2021年12月发布的2021版不在预警名单中
2020年12月发布的2020版不在预警名单中
74.65%60%-
CiteScore:12.10
SJR:2.063
SNIP:1.738
学科类别分区排名百分位
大类:Medicine
小类:Pharmacology (medical)
Q1
10 / 275
大类:Medicine
小类:Neurology (clinical)
Q1
24 / 400
大类:Medicine
小类:Pharmacology
Q1
23 / 321

期刊高被引文献

Neuroprotective and Antioxidant Effect of Ginkgo biloba Extract Against AD and Other Neurological Disorders
来源期刊:NeurotherapeuticsDOI:10.1007/s13311-019-00767-8
Neuroprotection of Fasting Mimicking Diet on MPTP-Induced Parkinson’s Disease Mice via Gut Microbiota and Metabolites
来源期刊:NeurotherapeuticsDOI:10.1007/s13311-019-00719-2
Treatment Responsiveness in KCNT1-Related Epilepsy
来源期刊:NeurotherapeuticsDOI:10.1007/s13311-019-00739-y
Peripheral Administration of IL-13 Induces Anti-inflammatory Microglial/Macrophage Responses and Provides Neuroprotection in Ischemic Stroke
来源期刊:NeurotherapeuticsDOI:10.1007/s13311-019-00761-0
Activation of Melanocortin 1 Receptor Attenuates Early Brain Injury in a Rat Model of Subarachnoid Hemorrhage viathe Suppression of Neuroinflammation through AMPK/TBK1/NF-κB Pathway in Rats
来源期刊:NeurotherapeuticsDOI:10.1007/s13311-019-00772-x
Molecular Mechanisms and Therapeutics for the GAA·TTC Expansion Disease Friedreich Ataxia
来源期刊:NeurotherapeuticsDOI:10.1007/s13311-019-00764-x
Extending the Interval of Natalizumab Dosing: Is Efficacy Preserved?
来源期刊:NeurotherapeuticsDOI:10.1007/s13311-019-00776-7
Intranasal Losartan Decreases Perivascular Beta Amyloid, Inflammation, and the Decline of Neurogenesis in Hypertensive Rats
来源期刊:NeurotherapeuticsDOI:10.1007/s13311-019-00723-6
Consequences of Metabolic Disruption in Alzheimer’s Disease Pathology
来源期刊:NeurotherapeuticsDOI:10.1007/s13311-019-00755-y
Antisense Oligonucleotides for the Treatment of Inner Ear Dysfunction
来源期刊:NeurotherapeuticsDOI:10.1007/s13311-019-00729-0
Levo-corydalmine Attenuates Vincristine-Induced Neuropathic Pain in Mice by Upregulating the Nrf2/HO-1/CO Pathway to Inhibit Connexin 43 Expression
来源期刊:NeurotherapeuticsDOI:10.1007/s13311-019-00784-7
Plasma-Based Strategies for Therapeutic Modulation of Brain Aging
来源期刊:NeurotherapeuticsDOI:10.1007/s13311-019-00746-z
A Longitudinal Study of the Neurologic Safety of Acute Baclofen Use After Spinal Cord Injury
来源期刊:NeurotherapeuticsDOI:10.1007/s13311-019-00713-8
FG-4592 Improves Depressive-Like Behaviors through HIF-1-Mediated Neurogenesis and Synapse Plasticity in Rats
来源期刊:NeurotherapeuticsDOI:10.1007/s13311-019-00807-3
A New Era for Surgical Neurotherapeutics
来源期刊:NeurotherapeuticsDOI:10.1007/s13311-019-00709-4
Blood Pressure Control and Protection of the Aging Brain
来源期刊:NeurotherapeuticsDOI:10.1007/s13311-019-00747-y
Gender-Specific Beneficial Effects of Docosahexaenoic Acid Dietary Supplementation in G93A-SOD1 Amyotrophic Lateral Sclerosis Mice
来源期刊:NeurotherapeuticsDOI:10.1007/s13311-019-00808-2
Diagnosis and Management of Alcohol Use Disorder in Patients with Liver Disease: Lights and Shadows
来源期刊:NeurotherapeuticsDOI:10.1007/s13311-019-00802-8
Calming Down Mast Cells with Ketotifen: A Potential Strategy for Multiple Sclerosis Therapy?
来源期刊:NeurotherapeuticsDOI:10.1007/s13311-019-00775-8
Molecular Mechanisms and Future Therapeutics for Spinocerebellar Ataxia Type 31 (SCA31)
来源期刊:NeurotherapeuticsDOI:10.1007/s13311-019-00804-6
Transcranial Magneto-Acoustic Stimulation Improves Neuroplasticity in Hippocampus of Parkinson’s Disease Model Mice
来源期刊:NeurotherapeuticsDOI:10.1007/s13311-019-00732-5
The Novel Small Molecule TRVA242 Stabilizes Neuromuscular Junction Defects in Multiple Animal Models of Amyotrophic Lateral Sclerosis
来源期刊:NeurotherapeuticsDOI:10.1007/s13311-019-00765-w
Repeat Expansion Disorders: Mechanisms and Therapeutics
来源期刊:NeurotherapeuticsDOI:10.1007/s13311-019-00823-3
Connexin Hemichannel Block Using Orally Delivered Tonabersat Improves Outcomes in Animal Models of Retinal Disease
来源期刊:NeurotherapeuticsDOI:10.1007/s13311-019-00786-5
Effects of Natalizumab and Fingolimod on Clinical, Cognitive, and Magnetic Resonance Imaging Measures in Multiple Sclerosis
来源期刊:NeurotherapeuticsDOI:10.1007/s13311-019-00781-w
Glial Cell Line–Derived Neurotrophic Factor and Chondroitinase Promote Axonal Regeneration in a Chronic Denervation Animal Model
来源期刊:NeurotherapeuticsDOI:10.1007/s13311-019-00745-0
Induction of Neuronal PI3Kγ Contributes to Endoplasmic Reticulum Stress and Long-Term Functional Impairment in a Murine Model of Traumatic Brain Injury
来源期刊:NeurotherapeuticsDOI:10.1007/s13311-019-00748-x
Assessing the Metabolomic Profile of Multiple Sclerosis Patients Treated with Interferon Beta 1a by 1H-NMR Spectroscopy
来源期刊:NeurotherapeuticsDOI:10.1007/s13311-019-00721-8
Moving Towards Therapy in SCA1: Insights from Molecular Mechanisms, Identification of Novel Targets, and Planning for Human Trials
来源期刊:NeurotherapeuticsDOI:10.1007/s13311-019-00763-y
Intranasal Neuropeptide Y Blunts Lipopolysaccharide-Evoked Sickness Behavior but Not the Immune Response in Mice
来源期刊:NeurotherapeuticsDOI:10.1007/s13311-019-00758-9
Subcutaneous administration of β-hydroxybutyrate improves learning and memory of sepsis surviving mice
来源期刊:NeurotherapeuticsDOI:10.1007/s13311-019-00806-4
Non-invasive Brain Stimulation for Alcohol Use Disorders: State of the Art and Future Directions
来源期刊:NeurotherapeuticsDOI:10.1007/s13311-019-00780-x
Correction to: Transcranial Magneto-Acoustic Stimulation Improves Neuroplasticity in Hippocampus of Parkinson’s Disease Model Mice
来源期刊:NeurotherapeuticsDOI:10.1007/s13311-019-00760-1
Long Noncoding RNA HOTAIRM1 Maintains Tumorigenicity of Glioblastoma Stem-Like Cells Through Regulation of HOX Gene Expression
来源期刊:NeurotherapeuticsDOI:10.1007/s13311-019-00799-0
Opioid Craving in Human Laboratory Settings: a Review of the Challenges and Limitations
来源期刊:NeurotherapeuticsDOI:10.1007/s13311-019-00791-8
Perfusion Enhancement with Respiratory Impedance After Stroke (PERI-Stroke)
来源期刊:NeurotherapeuticsDOI:10.1007/s13311-019-00744-1
Alcohol Use Disorder Interventions Targeting Brain Sites for Both Conditioned Reward and Delayed Gratification
来源期刊:NeurotherapeuticsDOI:10.1007/s13311-019-00817-1
At-Home Cortical Stimulation for Neuropathic Pain: a Feasibility Study with Initial Clinical Results
来源期刊:NeurotherapeuticsDOI:10.1007/s13311-019-00734-3
Molecular Signatures of the Aging Brain: Finding the Links Between Genes and Phenotypes
来源期刊:NeurotherapeuticsDOI:10.1007/s13311-019-00743-2
Receptor Tyrosine Kinases as Therapeutic Targets for Alcohol Use Disorder
来源期刊:NeurotherapeuticsDOI:10.1007/s13311-019-00795-4
Dalfampridine to Improve Balance in Multiple Sclerosis: Substudy from a Randomized Placebo-Controlled Trial
来源期刊:NeurotherapeuticsDOI:10.1007/s13311-019-00813-5
Tuberous Sclerosis (tsc2+/-) Model Eker Rats Reveals Extensive Neuronal Loss with Microglial Invasion and Vascular Remodeling Related to Brain Neoplasia
来源期刊:NeurotherapeuticsDOI:10.1007/s13311-019-00812-6
Abstracts from HSG 2019
来源期刊:NeurotherapeuticsDOI:10.1007/s13311-019-00788-3
Long-Term Follow-up in Patients with Spontaneous Intracerebral Hemorrhage Treated With or Without Surgical Intervention: a Large-Scale Retrospective Study
来源期刊:NeurotherapeuticsDOI:10.1007/s13311-019-00722-7
Autoimmune Epilepsy
来源期刊:NeurotherapeuticsDOI:10.1007/s13311-019-00750-3
Adhering to Ethical Benchmarks in Neurology Clinical Trials Using iPSCs
来源期刊:NeurotherapeuticsDOI:10.1007/s13311-019-00728-1
Nucleic Acid Vaccine Targeting Nogo-66 Receptor and Paired Immunoglobulin-Like Receptor B as an Immunotherapy Strategy for Spinal Cord Injury in Rats
来源期刊:NeurotherapeuticsDOI:10.1007/s13311-019-00718-3
Anti-Neuronal Antibodies Within the IVIg Preparations: Importance in Clinical Practice
来源期刊:NeurotherapeuticsDOI:10.1007/s13311-019-00796-3
Brain–Machine Interface Induced Morpho-Functional Remodeling of the Neural Motor System in Severe Chronic Stroke
来源期刊:NeurotherapeuticsDOI:10.1007/s13311-019-00816-2
One-Day Acceptance and Commitment Therapy Compared to Support for Depressed Migraine Patients: a Randomized Clinical Trial
来源期刊:NeurotherapeuticsDOI:10.1007/s13311-019-00818-0

相关文章

2026年3月发布
大类学科小类学科Top期刊综述期刊
医学1区
CLINICAL NEUROLOGY 临床神经病学
2区
NEUROSCIENCES 神经科学
2区
PHARMACOLOGY & PHARMACY 药学
1区
N/A
2025年3月升级版
大类学科小类学科Top期刊综述期刊
医学2区
PHARMACOLOGY & PHARMACY 药学
1区
CLINICAL NEUROLOGY 临床神经病学
2区
NEUROSCIENCES 神经科学
2区
2023年12月旧的升级版
大类学科小类学科Top期刊综述期刊
医学2区
CLINICAL NEUROLOGY 临床神经病学
2区
NEUROSCIENCES 神经科学
2区
PHARMACOLOGY & PHARMACY 药学
2区